<DOC>
	<DOCNO>NCT02174666</DOCNO>
	<brief_summary>The aim project execute double-blind , parallel , randomize 12-month intervention trial postmenopausal woman osteopenia ( low bone mineral density ) , order determine effect daily intake ferment red clover ( RC ) extract estrogen dependent bone mineral resorption compare placebo . Both group recieve equivalent daily calcium , vitamin D magnesium supplement . The project also assess whether bioactive compound RC reduce risk develop cardiovascular disease .</brief_summary>
	<brief_title>Isoflavone Treatment Postmenopausal Osteopenia .</brief_title>
	<detailed_description>The project aim determine whether red clover derive isoflavones capability exert positive effect condition osteoporosis osteopenia state estrogen deficiency and/or dysregulation . The cause osteopenia woman think arise deficiency and/or dysregulation estrogen target tissue . Hormone Replacement Therapy ( HRT ) proven effective treatment , however retain limited use general consensus also increase cancer risk . Plant derive compound emulate chemical structure behaviour estrogen ( know isoflavones ) offer compel alternative HRT , due potential adopt regulatory role estrogen without incur equivalent negative side effect HRT . There , present , direct head head clinical trial assess combination treatment isoflavones , vitamin D calcium contrast standard vitamin D calcium supplementation proscribe osteopenic patient . Research area therefore provide valuable insight effectiveness isoflavones reduce resorption and/or stimulate formation bone tissue . Moreover study provide comprehensive assessment potential isoflavones enhance efficacy exist preventative treatment . Outcomes project prospect help thousand middle age PM woman suffer . Moreover , project may enable development functional food and/or nutraceuticals use either preventative measure and/or treatment osteoporosis state estrogen deficiency thereby provide alternative Hormone Replacement Therapy involve side effect risk .</detailed_description>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Bone Diseases , Metabolic</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Calcium , Dietary</mesh_term>
	<criteria>Inclusion criterion : Age 5085 year , woman Have osteopenia ( T score 1 2.5 ) Body Mass Index ( BMI ) 20 40 Exclusion criterion : Taken specific osteoporosis drug ( i.e . bisphosphonates , PTH , estrogen strontium ranelate ) past 3 month Taken selective estrogen receptor modulator preparation ( raloxifene , tamoxifen isoflavones ) past 3 month Participation clinical trial within last 3 month Previous history cardiovascular , psychiatric , neurological , / kidney disease Alcohol substance abuse acute illness Blood pressure &gt; 160/110 Pregnant breastfeeding woman</criteria>
	<gender>Female</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Aglycones</keyword>
	<keyword>Isoflavones</keyword>
	<keyword>Red clover</keyword>
	<keyword>Osteopenia</keyword>
	<keyword>Menopause</keyword>
	<keyword>Bone turnover</keyword>
	<keyword>Bone mineral density</keyword>
</DOC>